If the hypothesis that hypersensitivity phenomena are basic in the pathogenesis of collagenous diseases is accepted, the presence of an antigen, the nature of which remains to be determined, must be postulated.
Pleuropneumonia-like organisms have been implicated in rheumatic diseases. Their significance as possible antigens in collagenous disease hypersensitivity states is at present under investigation.
The unique properties of human " L " organisms would satisfy the criteria of a persistent living antigen, invisible in tissues or invaded cells. These properties also preclude their direct demonstration as aetiological agents.
In vitro studies on 28 strains of human " L " organisms reveal marked differences in sensitivity to antibiotics, myochrysine, and nitrogen mustard.
Preliminary studies indicate that antibiotics effective in vitro are also effective in vivo. This is manifested by disappearance of demonstrable " L " organisms during administration of aureomycin, chloramphenicol, or terramycin, and by transient exacerbation of clinical symptoms of collagenous diseases. The severity of this reaction parallels the in vitro effectiveness of antibiotics. It can be graded by dosage or route of administration (oral or intravenous). The exacerbation is not due to drug hypersensitivity. It may represent tissue response to antigen release, induced by antibiotics. It can be modified by administration of agents interfering with hypersensitivity reactions.
Discussion.-DR. BROWN: During the past few years many new and hopeful remedies for arthritis have been announced, but after clinical trial and prolonged treatment, each has finally been proven either limited or useless in providing persistent, adequate control of rheumatic diseases in general. The practising physician has encountered patient disappointment and medical uncertainty on account of these failures.
We have long believed that lasting benefit would be possible only when there was a thorough understanding of the basic mechanism operating in collagen diseases in general. To date there has been no real understanding of the mechanism.
To-day we have proposed a new total concept of this mechanism, based on clinical and laboratory studies extending over the past 12 years. We suggested a new clinical approach in June, 1949 , and the methods of management making use of it to-day are very encouraging, but we believe 463 group of organisms knows that preparation of satisfactory antigens is still a difficult procedure.
But it is possible, and work in this direction should be continued and extended. As far as the relation of change of course of collagenous diseases and aetiological agent is concerned, I agree that we should not draw hasty conclusions. In our own minds the exacerbation that follows the administration of certain antibiotics has been more important than any improvement, as far as attempts to understand the basic mechanism of these diseases are concerned. These exacerbations, possibly related to the effect of antibiotics on L organisms with subsequent antigen release into a system where antibody is readily available, have occurred with great regularity. Adrenal Function and Steroid Hormone Metabolism in Health and Disease. By KONRAD DOBRINER, New York (by invitation). Steroid excretion patterns in man have been studied as a means of defining the details of hormone production by the adrenals and gonads. The evidence, which correlates the metabolism of normal or abnormal adrenal hormone production in arthritis, is compared with the findings in healthy subjects and in patients with neoplastic disease. The capacity of the adrenal to respond to stimulation by ACTH, in patients with arthritis, and type and character of the response is presented. The metabolism of cortisone in an arthritic patient and the change in steroid pattern during pregnancy are correlated with the arthritic syndrome.
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administered is rather puzzling. That they should disappear with cortisone is understandable, but I should have expected them to increase on the administration of ACTH if the urinary metabolites are derived from an abnormal steroid produced by the adrenal. The fact that they disappear suggests the possibility that the primary defect may lie in the pituitary, which may be secreting an abnormal form of ACTH and that adrenal function reverts to normal when ACTH is given by injection. I should certainly like to hear Dr. Dobriner's views on this point.
Observations on Local Action of Adrenocortical Steroids. By BURTON L. BAKER, Ann Arbor, Mich. (by invitation) . In contrast to numerous other types of hormones, it is possible to demonstrate a localized action by adrenocortical hormones, particularly those of the C-Il oxygenated group. This spatial limitation of effect appears to be made possible by a rapid peripheral utilization of the adrenal hormones, so that, at low doses, the amount absorbed into the blood stream is insufficient to exert a systemic effect. In addition to other structures, fibro-elastic connective tissue is modified by the local action of adrenocortical steroids with all its major components involved, including cells, fibres, and ground substance.
Prolonged direct application to the skin of adrenal extract causes thinning of the dermis with involution of fibroblasts, a temporary retardation in the formation of granulation tissue, and acceleration in the spreading action of hyaluronidase. These modifications are limited, for the most part, to the area of application. However, they cannot be maintained indefinitely because ultimately the skin returns to normal in spite of continuation of the treatment. Thus, a local loss in responsivity to the action of the adrenal hormones is demonstrated. When compared on the basis of their capacity to inhibit growth of hair by local action, the C-11 oxygenated steroids are more potent than the C-11 non-oxygenated steroids. Nevertheless, 1 1-desoxycorticosterone in large doses will inhibit the growth of hair and accelerate the spreading action of hyaluronidase. Many of the connective tissue responses to adrenocortical steroids are illustrated in striking fashion in the tissues immediately surrounding implanted pellets of pure adrenal steroids. Alterations in fibroblasts seem to be of primary significance in accounting for the other effects of adrenal hormones on connective tissue.
Discussion.-DR. CHARLES RAGAN (New York): I wish to compliment Dr. Baker on his paper, which is a superb piece of work.
Our main concern has been with the response of tissue to trauma as modified by the parenteral administration of cortisone, and our results corroborate those of Dr. Baker. Certainly, we can confirm everything he has said concerning the response of traumatized tissue.
However, I think that the interpretation of these results is still open to some speculation, and we, as clinicians, have found ourselves in the middle of a controversy of anatomists concerning the origin of the fibroblast, about which there are two schools of thought. The one which is most attractive, which would fit into this hypothesis, is that championed by Bloom and his school, who feel that at least one of the precursors of the fibroblasts is the macrophage. It has been shown by Dougherty and Spain that, during hyperadrenalism in animals and in humans, there is a decrease in the number of wandering cells and macrophages in an area of trauma.
Lurie and Gordon have shown that in situ the macrophage is phagocytic, Lurie in liver and Gordon in spleen. We have done this with local traumatized areas and find that in vivo the macrophage is phagocytic but does not wander into an area. The next phase in the inflammatory process has been studied by Duthie (Edinburgh), and by Bethel (Ann Arbor), who have found there is a decrease in capillary permeability after the administration of ACTH or cortisone.
The next phase in the modification of the inflammatory process has been studied by Ebert, Michaels, and Wood who have found that there is a decrease in margination of leucocytes in capillaries round an area of trauma, during hyperadrenalism.
Which is the first site to be modified in this modification of the inflammatory reaction ? We are not prepared to say whether one must start with the inability of the leucocytes to marginate through either the decreased capillary permeability or a decrease in the number of invading macrophages or in fibroblast proliferation.
We Fifty adult white rats, divided equally as to sex, were given intramuscular injections of cortisone acetate 3 mg. daily for 11 days. This dose was ten times the equivalent of a human dose of 100 ANNALS OF THE RHEUMATIC DISEASES mg./day and the 11-day injection period in the rat was equivalent to 1 year of life in man. Sixty-six rats provided suitable control material. The cortisone-treated rats were divided into five groups. Group 1 was killed at the end of the injection period to determine the probable maximal cortisone effect. The other four groups were killed at various periods after the last injection, corresponding to 4, 6, 15, and 33 months in man, and the effect of cortisone was determined by adrenal-gland weight and by histologic study of the adrenals stained by haematoxylin-eosin and Sudan IV. Histologically the effect of cortisone upon the adrenal gland consisted of a narrowing of the cortex and a decrease in the sudanophilic material in the cytoplasm of cells of the fasiculata and reticular zones. These were not identical in the sexes. In the male rats the effect of cortisone reached a maximum at the 6-month period and then improved, so that at 15 and at 33 months the effect was absent. In the female rats the cortisone effect present at the 1-and 4-month periods was less pronounced than in the males; at the 6-month period the females showed a slight decrease in sudanophilic material, whereas the males at this period had shown the most marked effect; at 15 and 33 months the female adrenals appeared normal.
On the basis of adrenal weight, the female rat adrenal had completely recovered after a period corresponding to 6 months in man, whereas the male adrenal was not completely normal at this period. Both sexes showed complete recovery at 15 months. The adrenal of the treated male rat always showed a greater decrease in weight as well as greater reduction in the sudanophilic substance than did the adrenal of the female rat.
These studies showed that the adrenal glands of the adult white rats injected daily with cortisone in doses ten times the equivalent of the human dose of 100 mg. a day, for a period corresponding to one year in man, completely recovered from the changes effected by the steroid. No permanent damage was found, and recovery from the cortisone effect was more rapid in the female.
DR To attribute to cortisone the capacity to inhibit in the bone marrow a natural granulocytic response to inflammation, may lead one erroneously to shift the emphasis from the local inflammatory lesion to a haematopoietic structure, as the important site of cortisone action. The results reported by Dr. Tillis and Dr. Goldman are at variance with those published last year by Rosenthal, Yager, and Litwins of New York. The differential counts in the bone marrow of a series ofpatients with rheumatoid arthritis treated with cortisone by these workers showed no significant change. For example, before and after cortisone, the myelocyte count was 22 and 24 per cent., the nonsegmented neutrophil count was 30 per cent., the segmented neutrophils were 14 and 13 per cent., and the eosinophil count was 3 per cent. More recently, Sussman and Antopol conducted similar studies in cortisone-treated mice and again found no " inhibitory effect of cortisone on cell proliferation in the bone marrow".
We should like to ask Dr. Tillis whether the fall in the immature granulocytes may not have been secondary to a relative increase in the lymphocytes or mature granulocytes. Is it not possible that the Iymphocytosis in the bone marrow was secondary to the lymphopenia in the peripheral blood ? Would not the hypothetical anti-inflammatory effect of cortisone imply an inability of the bone marrow to respond adequately to an intercurrent infection ? DR. C. L. STEINBERG (Rochester, N.Y.): What interested me was not so much the lymphocyte response that Dr. Tillis emphasized, but the change in the plasma cells. If you recall, he reported that the plasmacytes increased to an average of 0 6 from 0 3 per cent.; and if one recalls that the plasmacytes are markedly increased in the bone marrow in the disease multiple myeloma, and that in the same disease the gamma globulin is markedly elevated, and if one keeps in mind that gamma globulin is intimately associated with the immune response, then certain conclusions may be drawn.
Gamma globulin is increased in disseminated lupus erythematosus, which is the opposite of what one would expect. The total globulin is usually elevated, and when the response to either ACTH or cortisone is obtained, the total globulin drops. Other observers have seen the same thing to occur in rheumatoid arthritis.
It seems to me that one of the reasons for the discrepancy given this morning is the fact that 500 cells are insufficient to count, since at least 5,000 cells are required in order to be reasonably accurate as to the haematological picture that is present in the bone marrow.
Lastly, I wish to bring up a controversial point. Are the lymphocytes produced in the bone marrow ? The bone marrow has been diluted with peripheral blood by this method, and we are not getting a true picture of what is occurring in the bone marrow.
DR. ABRAHAM S. GORDON (Brooklyn, N.Y.): I want to ask Dr. Tillis what method he used in the study of the contents of the bone marrow. I think the entire picture of the changes noted depends upon the method used in the study of the cellular content of bone marrow, but that is not described. Can he give us any details on this matter ? How did he dispose of the intercellular substance, or the walls of the sinuses of the marrow, and how did he dispose of the fat in the marrow ?
I call attention to this because about fourteen years ago I described a special method of studying cellular contents of marrow and went into great detail to eliminate all the extraneous material so as to be able to show exactly the differential elements in the diferent types of the cells in the marrow. I therefore think the method used is extremely important.
Often unidentified cells or very early primordial cells are mistaken for lymphocytes. The results may vary, depending upon the technique. I have seen some of these data on the screen and they are completely at variance with some of my findings when studying the marrow. DR. TILLIS: As regards the erythroid elements, we felt we could arrive at no conclusions. It must be realized how this study was started. It was done in a routine examination early in 1950, when we were trying to evaluate patients who had taken cortisone; at that time we did not know what the effect of cortisone on the bone marrow was going to be, any more than we knew what its effect was going to be on the spinal fluid which we stqdied. We felt that because of the transfusions and the haematinics we could arrive at no conclusions regarding erythroid elements, and therefore made no effort to do so.
Regarding eosinophil studies on mice, the dosage that was used over a period of 17 days was so tremendous that I feel that no observer can compare them with the human from that standpoint. Regarding the technique of bone marrow aspirations, Dr. Goldman performed these in the manner that is usual in our hospital.
Our findings showed an increase of the lymphocytes in the bone marrow after cortisone therapy. A MEMBER: I should like to ask Dr. Bauer whether these were uniform findings in all the various parts of the heart and whether they were examined in different sections.
I should also like to ask him if any Aschoff bodies were present in any of the hearts that he examined, and to the question that has just been asked, whether the same lesions were not found in other parts of the vascular system or in other parts of the body.
DR. BAUER: I called attention to the fact that although all patients had spondylitis, approximately 75 per cent. of them also had peripheral joint disease. To date, we have not seen this type of valvular heart disease in patients with only peripheral joint involvement. In two cases the peripheral joint disease was so marked that the minimal spondylitis might have been overlooked. In some of these patients the disease began in the peripheral joints, and evidence of spondylitis was not seen until some years later. i Cases of this type indicate the need for determining the incidence of spondylitis in rheumatoid arthritis of the peripheral type. This can only be established by obtaining routine X rays of the spine in a large number of such cases.
Our group has always considered spondylitis as a form of rheumatoid arthritis and not as a distinct disease entity. We admit that the absence of nodules and the predominance of males in patients with spondylitis favour the latter point of view. However, much about rheumatoid arthritis remains unknown, and until these gaps in our knowledge are filled, we cannot explain exceptions or establish additional disease entities.
Regarding lupus erythematosus, the answer is No. We have treated two such cases with ACTH without favourable effect on the heart disease.
One of the patients with pericardial nodules had approximately one hundred subcutaneous nodules, but no nodules were found in the myocardium of the cases here reported, though they have been observed by Rosenberg and others. Dr. Kantor talked about fibrinoid, the morphologically distinct substance. He has demonstrated a type of approach by which we may be able to determine the chemical nature of this substance. The next step will be to determine the nature of the relationship between fibrinoid and the degenerative changes in the connective tissue, which are the most obviously damaging features of the rheumatic lesions.
DR. GRANVILLE A. BENNETT (Chicago, Ill.): Some years ago, when being pushed to state what fibrinoid is, I could think of nothing better to say than that it represents something added to connective tissue, perhaps only plasma soaking of connective tissue. I feel that the present study lends support to the concept some of us have had that fibrinoid is not strictly a change in the composition of collagen.
I think that fibrinoid change-and I prefer to speak of it as fibrinoid change rather than fibrinoid degeneration since we do not know just what the alteration is-is seen in various stages of development. The lesions that were demonstrated so beautifully this morning, are possibly late lesions. If we were to look at some of the earlier lesions we might find material that stains histochemically in the characteristic fashion of fibrinoid, but we might see connective tissue fibrils extending completely across the lesion at the same time.
In what we consider to be older lesions, complete breakdown of all the connective tissue substances occurs in the centre of the nodules. In fact, some lesions become cystic and may contain only yellowish, amorphous, glandular or curdlike material in their centres.
Thus the degree of change or the amount of disintegration of connective tissue depends, I believe, upon the duration of the lesion. The older nodules show the most complete breakdown.
I hope you will comment on your findings in light of the stages of development of the nodules. DR. CURRLER MCEWEN (New York): I can add only the comment that most people have been somewhat dissatisfied with the term " collagen diseases " and that this is perhaps one more reason to be dissatisfied with it. DR. HuGo A. FREuND (Detroit, Mich.): I am glad that the distinction was made between the formation of fibrinoid and fibrinoid degeneration. Fibrinoid is formed in so many different conditions. We have been particularly interested in fibrinoid in our pathological laboratories, because we know that fibrinoid is found in many allergic manifestations, in the Aschoff body, in lymphocytic accumulations, and, as discussed to-day, in subcutaneous nodules. Altshuler and Angevine (1949) group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from AMERICAN RHEUMATISM ASSOCIATION from nodules that have been present from 1 to 3 years. However, we were quite definite in picking solid, and therefore, presumably younger, portions of the nodules for analysis. In fact, only one of the nodules had cystic change in one portion.
Dr. Bennett's point about the earlier lesions looking as though they were " painted " with fibrinoid material is a good one. We think that is probably what the process represents. Once one takes the fibrinoid material out, normal collagen is apparently left underneath. It is as though fibrinoid material were absorbed on to the collagen fibres. We did have one early lesion which had been present for a week or 10 days, but to our dismay, we lost it because of technical difficulties.
Dr. McEwen pointed out that the concept of collagen disease is perhaps seriously affected by this work. Klemperer (1950 Klemperer ( , 1951 has pointed out the inherent dangers in this concept. His concept of collagen disease has little to do with the protein collagen itself. He originally meant, in the older pathological sense, to include an equal consideration of all of the intercellular elements of the connective tissue. Thus, he includes in this concept the ground substance elements and elastin as well as the collagen fibre. Discussion.-DR. CARL STEVENSON (New York): We have had experience with theintra-articular injection of Compound F acetate in fourteen patients with rheumatoid arthritis; one had injections into the hip joint, and the others into the knee joints. The initial dose was always 25 mg., with subsequent doses of 25 or 50 mg. Injections were made at intervals of from 3 to 42 days. The short intervals occurred during the early part of this study when an attempt was made to suppress all signs of iiflammation in the treated joint. In this group of patients, twelve of the fourteen reported more than 50 per cent. relief from pain and stiffness; six patients reported complete relief of symptoms when injections were made weekly. The degree of symptomatic improvement did not always parallel the objective changes. In most instances the patient reported relief from pain and stiffness before there was a significant change in the physical signs. There was, however, a moderate to complete improvement in the injected joints of eleven of the fourteen patients. During the interval between injections objective worsening appeared 2 to 14 days before symptomatic worsening.
These preliminary studies suggest the following generalizations:
(1) Compound F can be given safely into the joint cavity.
(2) It has a local suppreasive effect on joint inflammation as measured clinically in most patients.
Evidence that the effect is local is shown by the complete absence of changes in other joints.
(3) 50 mg. Compound F acetate usually produced a greater improvement with longer duration than doses of 25 mg.
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(5) The average duration of improvement was between 10 and 20 days after injection; two patients showed improvement for 28 and 42 days respectively.
(6) The cell count of joint fluid showed a decrease in total cells with a return of lymphocytes in all patients.
DR. MARIAN W. RoPEs (Boston, Mass.): Dr. Hollander's report of the temperature changes in cortisone and Compound F are clear-cut. Has he any explanation of their meaning as regards the physiology of the joint.
We have not tried Compound F, but have given cortisone by intra-articular injection to three patients. All had some subjective and objective improvement, but we found that the cell count in the synovial fluid was usually the same or slightly elevated. The polymorphonuclears fell in one case, and viscosity rose in all cases, to the same degree as one would expect from intramuscular or oral cortisone.
There were two unusual findings: in one patient with bilateral knee effusions, radio-active sodium entered more rapidly into the treated joint than into the opposite joint, which perhaps indicates increased inflammation in the joint into which cortisone was injected. In another patient the electrophoretic pattern of fluid showed a remarkable change; the gamma globulin fraction rose from 20 to 25 per cent. and the albumin dropped from 39 to 34 per cent.
DR. DAVID H. KLING (Los Angeles, Calif.): I have given intra-articular injections of cortisone in a large number of cases; the doses varied from 50 to 100 mg. repeated after 48 to 72 hours. Various degrees of clinical improvement were found in the majority. Re-aspiration showed a diminution of inflammation: increase in viscosity, and decrease of total cell counts and polynuclear leucocytes. However, the effects were of no longer duration than after intramuscular injections, which was disappointing as we had hoped that a depot of cortisone in the joint cavity would be only slowly absorbed and would thus have a prolonged effect. Re-aspiration, 48 hours after injection showed that the effusion contained a sediment of granular and crystalline material derived from the injected cortisone. Samples of this sediment were submitted for analysis to the Merck Laboratory, and Dr. Gibson informed me that they were unable to identify cortisone in the material.
Disintegration of cortisone by the metabolic activity of inflamed synovial tissues may explain the failure to prolong its therapeutic effect by intra-articular injections.
However, I cannot subscribe to the idea that cortisone has only a systemic effect while Compound F exerts a powerful local action. This is contradicted not only by our own experience of the immediate beneficial effect of intra-articular injections but also by the pronounced effect of local application of cortisone in some eye conditions. Intra-articular temperature measurements are valuable but are not the only reliable indicators, of inflammatory activity in the joint cavity. Clinical aspects, such as swelling, stiffness, tenderness, local skin temperature, and analysis of joint effusions, are of equal or greater importance. DR. J. J. BUNIM (New York): Injection of 50 mg. cortisone acetate into the knee joints of twelve patients with rheumatoid arthritis resulted in eight in marked to moderate improvement locally. The pain, swelling, stiffness, and effusion diminished or disappeared. In the remaining four patients, there was no improvement. When cortisone was introduced into the knee several weeks after the patient had been receiving cortisone by mouth or intra-muscularly, local improvement in the articular symptoms was definitely augmented. Therefore, if it be reasoned (but this is all theoretical), that cortisone given systemically reaches the articular tissues as Compound F, it would then appear that, in the absence of evidence that synovial tissue in rheumatoid arthritis has the ability to reduce Compound E to Compound F, larger amounts of " E " are more effective than smaller amounts of " F ". In other words, if there is a difference in the action of these compounds, it would seem to be a quantitative one.
It has recently been demonstrated by Karnofsky of the Sloan-Kettering Institute that the differences between the biological effects of cortisone and Compound F vary in different experimental animals. Whereas, in the chick embryo, Compound F was found to be 30 times, and in the newly-hatched chick about 100 times, more active than cortisone, in new-born mice cortisone and Compound F were found to have the same degree of biological activity. Dr. Heard arrived at a similar conclusion when assaying these two hormones by sev6ral different techniques in mammalian systems.
In a patient with rheumatoid arthritis 50 mg. Compound E acetate was injected into one knee and 50 mg. Compound F acetate into the other. The synovial fluid from each joint was analysed before and after each injection and in addition to total and differential leucocytes counts, the activity of an amino-peptidase enzyme in the synovial fluid which splits glycyl-glycyl-glycine was also determined (see Table) . I should like to add here that, although studies on the enzyme activities of synovial fluid in our laboratory have not yet been completed, our results hitherto indicate that the concentration of amino-peptidase in the synovial fluid is probably related to the type and density of cellular infiltration in the synovial tissue. In general, synovial fluid from rheumatoid and tuberculous joints contain significantly greater concentrations of peptidases than fluid from patients with rheumatic fever, or gonococcic, traumatic, or osteo-arthritis.
The peptidase activity of serum was 5-9 before, and 7-8 after, cortisone administration. It is our impression that cortisone injected intra-articularly is of definite value in properly selected cases, but further experience may prove that compound F is more effective. , is equally as effective as Compound E, and that any differences in antirheumatic effects may be due to the factor of absorption. Have studies been made to determine relative rates of absorption from the joint of these two compounds. We stopped our study with intra-articular cortisone, because, on the basis of eosinophil counts, we did not feel we were keeping the hormone in the joint long enough to get a local effect. If-Compound F is absorbed more slowly, its local effects may be due rather to having a higher concentration in thej oint for a longer period, than to any qualitative differences between the two hormones. Referring to Dr. Bunim's case, which showed equal effects, with E and F, we have tried two such experiments with E in one joint and F in another, in cases already on cortisone. I think that the results of such an experiment are open to question. When you inject 50 mg. F into one knee and 50 mg. E into the other, there is no question that the addition to the systemic cortisone already used will have increased systemic effects which will certainly affect both knees.
In answer to Dr. Massell's question about the vehicles used, the two preparations used were E and F acetate, and the particle size was identical. We tried experiments using E alcohol, which is ten times more soluble than E acetate, and we tried cortisone tricarballylate solution locally, but neither was comparable to F acetate in local anti-inflammatory effect.
In response to Dr. Boland's remark about systemic Compound F being inferior to E, we, too, have observed less striking effects from F in the few cases we have treated systemically. We feel it may be necessary to give F frequently, in smaller doses, rather than in the single large doses of cortisone which we have been accustomed to use.
Concerning Dr. Robinson's comparison studies: in our experiments we have tried to cover the effects of both single and multiple injections. Most of our clinical effects were measured on the basis of one injection, observed until the patient experienced a partial relapse, followed by another one, and so on-not pyramiding the injections, but waiting until the first effect was over, as we wanted to see how long the benefit would last.
In Early and severe relapse of the disease after cessation of cortisone was the rule even after prolonged treatment and in patients with disease in short duration, no matter how the hormone was given. Entirely separate from relapse of the arthritis is the problem, in some patients, of severe and prolonged " post-cortisone withdrawal syndrome ". Therefore, the importance that the hormone be not considered routine treatment in patients with rheumatoid arthritis is emphasized and the necessity is stressed that the following two questions (not one), be considered before cortisone treatment is decided upon:
(1) What will happen when cortisone is administered ? (2) What will happen when the hormone is discontinued ? In all patients the antirheumatic effect was comparable to that resulting from the intramuscular administration of cortisone.
In most instances the required dose of cortisone was approximately the same for the oral as for the intramuscular preparation. Some cases required slightly more of the oral than of the intramuscular material. Occasionally oral cortisone seemed more effective.
The main difference between the effect of oral and intramuscular cortisone was the greater speed of onset and the more rapid wearing off of the antirheumatic effect in the case of oral cortisone. The daily dose of oral cortisone should be divided and spaced more or less equally throughout the 24-hr period.
Side-effects resulting from oral administration were similar qualitatively to those seen in cases treated by the intramuscular injection. The incidence of side-effects depended largely upon the factors of dosage, duration of treatment, and susceptibility of the patient. In a very few cases some gastro-intestinal irritation followed oral administration. In many cases it was possible to maintain a good antirheumatic effect by the use of relatively small doses of oral cortisone which did not lead to the development of significant side-effects during the several months of administration. The likelihood of promoting and sustaining satisfactory improvement depended on the initial severity of the rheumatoid arthritis more than on any other single factor. This, we think, is important, and we believe that the correlation of disease severity to results has not been sufficiently emphasized. Slightly less than 50 per cent. of severe cases were maintained under adequate control by long-term therapy, whereas the disease was satisfactorily suppressed in 70 per cent. of moderately severe cases and in 92 per cent. of moderate or mild cases. Although some severe cases failed to respond adequately even to large doses of cortisone, the chief detriment to good results was the intervention of adverse hormonal reactions. These developed at some time during the course of treatment in 40 per cent. of the patients. Whereas they were seldom of serious moment of themselves, their occurrence did influence the results. Their appearance, especially in severe cases, necessitated reduction of maintenance doses, sometimes to levels insufficient to provide desirable degrees of control of the rheumatic manifestations.
Adverse effects developed with much greater frequency when large doses of cortisone were employed. They rarely occurred with doses of 62 5 mg. a day or less, and in general their incidence was greater as larger doses of cortisone were used. The unwanted effects therefore were met most commonly during the early phase of suppressive therapy and in severe cases which required large maintenance doses.
The incidence of adverse reactions did not increase appreciably with prolongation of therapy. In our preliminary report given last year on uninterrupted administration for periods up to 4 months, tHe incidence was 35 -7 per cent. This compares favourably with the present incidence of 40 We have now had a large series of patients, some on cortisone over a year, some almost two years. In spite of holding these people in remission, in a certain percentage we have noticed the progression of the disease (by x ray, by increased porosis of the bone, and by continued loss of cartilage), in spite of the fact that the patient remained fairly well symptomatically. In regard to the dosage, we found an extreme variation. Some required high dosages to maintain the remission but, like other workers, we have seen complications.
However, I have one patient who has required as much as 150 mg. a day. She started over a year ago on the conventional routine; we tried to reduce the dosage, but each time she would have a flare-up of symptoms; now for the last 6 months she has been out of my control, being able to buy cortisone herself, and she has insisted on taking 150 mg. a day, in spite of all the warnings. However, I have visited her to observe the effects and she still shows no bad effects or toxic symptoms.
One other feature is that so many of these patients complain of lassitude; their joints, they tell me, feel like rubber; they don't feel well; they are often depressed. You can't put your finger on anything; you examine them and find no sign of infection; the blood count, sedimentation rate, and so forth show no essential change. But very frequently I have found they have had some infection, exemplified by a low-grade fever. This is not always apparent at the clinic, but at home a noon or evening temperature is often discovered.
Some of these temperatures can be reduced by a course of antibiotics, and within a few days the patient will say he has a marvellous remission and feels much better without changing the dosage.
DR. WILLIAM S. CLARK (Boston, Mass.): Dr. Hill has mentioned a problem which we have been somewhat concerned with, namely the progression of the disease under the influence of cortisone, when the dosages used suppress merely the symptoms.
We have had a number of patients under long-term therapy, and in following the literal requirements of the American Rheumatism Association Criteria, we have not seen Grade I or II remissions.
Although these patients are symptomatically better and even working, we have sometimes observed objective evidence of an increase in the severity of the disease. We have also seen x-ray evidence of progressive joint damage, and in three patients in whom we followed the synovial fluid serially, we found changes which would indicate an increase in the severity of the inflammatory process.
It We usually give 50 or 75 mg. daily, and 100 mg. in a very few cases. Many of this group would be bedridden to-day if they had not had cortisone.
I agree with Dr. Clark that the feeling of well-being is deceptive, and we caution our patients not to exercise too much merely because they feel well.
DR. J. J. BUNIM (New York): At Bellevue Hospital we treated two patients during an initial attack, and one during a recurrent attack, of acute rheumatic carditis with massive doses ofcortisone or ACTH after it had become apparent that they were not responding satisfactorily to usual doses. It is the impression of our group that no significant ultimate benefit was gained by large-dose administration. The resurgence of rheumatic activity following withdrawal of therapy, the total duration of illness, and the residual structural damage were not more favourably affected by massive than by ordinary doses, as is illustrated by this Table. Although the systemic effects and laboratory manifestations of the disease were all suppressed during the various courses, and to a greater degree during the periods of massive dose administrations, nevertheless the end results were not satisfactory.
DR. DAvI H. KLING (Los Angeles, Calif.): The introduction of oral administration has made the long-range use of cortisone more accessible to many patients, but unfortunately it has also made proper control of dosage much harder. Many patients are apt to modify the dosage either upwards or downwards, depending on the latest magazine or newspaper article they or their relatives have read; when it becomes necessary to discontinue the drug, such patients often find another doctor or pharmacist who will supply the tablets. This situation urgently requires the inclusion of cortisone among the dangerous and habit-forming drugs because addiction has occurred in addition to serious side effects.
The initial dosage should be high enough (between 200 to 300 mg. daily) to achieve the maximum improvement in the shortest time. This permits a quick evaluation of the reversibility ofthe process and gives the victim a glorious respite from rheumatoid arthritis. How long this vacation may be extended, how soon and how much the dosage can be reduced, depends on the circumstances, especially on the reactions, encountered in a given case. 480 group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from Therefore the maintenance dosage varies from patient to patient from a few to 100 mg. or more daily and has to be adjusted from time to time.
The percentage of cases which can be maintained comfortably on low doses for prolonged periods depends on the composition of the material. If early, mild, and moderately severe cases are the most numerous the percentage will be high; it will be low if severe cases of long duration predominate. Reduction of dosage below the level which gives definite amelioration defeats the objective of therapy. Where this becomes necessary, on account of reactions, complete suspension of the course of cortisone is the rational procedure.
Dr. Ward and his associates mentioned an increase of libido among the reactions, but this is an exception, for decrease in libido and potency during and for some time after cortisone therapy is the general rule.
DR. EDWARD F. ROSENBERG (Chicago, Ill.): During the past two years, I, like many other clinicians, have attempted to estimate the value of long-term administration of these hormones in rheumatoid arthritis. My attitude to-day is by no means pessimistic. Many disadvantageous side-effects and some accidents have been observed, but I consider this inevitable in view of the powerful action of these agents. The post-cortisone withdrawal syndrome is painful, and failure to obtain complete improvement is often distressing, but nevertheless, a long-continued administration of both cortisone and ACTH can often be successfully accomplished without evidence of toxicity or serious side-reactions.
A continued study of many dosage schemes is needed and we must continue to search for measures to supplement the effectiveness of these hormones.
Despite these unsolved problems, I feel no discouragement, and to me the future looks bright. DR. DOUGLAS TAYLOR (Toronto, Canada): I should like to ask four questions: First.-I know of one patient who, although under very careful control in hospital, with frequent "negative " x-rays of the chest, suddenly developed acute miliary tuberculosis while being treated with ACTH (and cortisone). I want to ask the doctors who presented these papers whether or not it has been their experience that tuberculosis is a dangerous complication; or whether or not they feel that our patient may have been an isolated exception.
Second.-I believe that the best way to relieve pain and prevent deformity in a joint is by the proper use of a splint, combined with heat and the correct type of graded exercise. I should like to know whether attention has been given to protecting involved joints by splinting or bandages.
Third.-We see in the public press accounts of arthritic patients who were " crippled " or "bedridden ", but who got up and danced and climbed ladders after receiving cortisone. I should like to know what happens in such cases to those joints which have been partly destroyed in advanced rheumatoid arthritis. It seems to me that in joints with eroded cartilages, swollen synovial membranes, and distended capsules, much additional damage would be caused. Has any study been made of the effect of this unwonted physical activity upon the damaged joints ?
Fourth.-This refers to a fact already mentioned, that a patient can get ACTH or cortisone outside his own doctor's control. Can a patient go into a drugstore in the U.S.A. and buy cortisone without a prescription ? A few patients have told me that after they had received the drug from a doctor they felt so well that they bought it on their own from a drugstore, and continued to use it without supervision. I think this is a dangerous situation with a drug so powerful, and still in the experimental stages There are a good many untoward reactions that have not been fully explored in these papers, and I should like to report our experience and also the information obtained by questionnaire on thrombo-embolic phenomena occurring during the use of these compounds. In my series of 100 patients, two developed myocardial infarction, and one thrombophlebitis during therapy. There were eighty replies to the questionnaire, and several hundred cases reported, but the data was insufficient in all except 1,036 cases. Thrombo-embolic phenomena occurred in eighteen patients in this group. At have seen diabetic changes in patients treated with cortisone in more than the two mentioned in this series. This complication has occurred in the early stages of cortisone treatment and the steroid has been discontinued; thus such patients are not included in the group of cases given prolonged treatment. However, we intentionally continued cortisone in two patients in order to study the metabolic changes. When the steroid was discontinued, the diabetes gradually subsided. We think that cortisone will change a latent to a manifest diabetes. However, we were surprised to find that ketosis did not occur, even though in one patient as much as 180 g. sugar was eliminated in the urine daily.
We did not attempt to prevent electrolyte changes; we wished to learn the incidence of such changes, so made frequent observations to study them. When they occurred, we attempted to correct or control them.
I believe I can best summarize the feelings of our research group by recalling to you that in January, 1950, I concluded a paper presented before the New York Academy of Medicine, with the statement that I did not share the pessimism of many investigators regarding the future of the clinical use of cortisone and ACTH in rheumatoid arthritis, but felt it was up to the physicians and the chemists to find out how to put these materials to safe and effective use. I still feel that not pessimism but conservatism is required-because of the limitations that these studies show.
Clinical investigators recognize potentialities of this agent for the benefit of rheumatoid arthritis. Never before has such a potent antirheumatic substance been available, but we need to know better how to use it.
Although we have been disappointed with some of our results, we are not discouraged from our search for satisfactory practical methods of treatment.
DR. SLOCUMB: I agree with Dr. Freyberg's closing remarks. Dr. Hartung mentioned 50 mg. cortisone daily as the top dose for many of his patients. I agree that 50 mg. is the highest daily dose well tolerated by many women in the menopausal or postmenopausal period and also by a few women who are menstruating regularly. However, most men will tolerate daily doses of 62-5 mg. or more without signs of hypercortisonism. For patients with rheumatoid arthritis, large initial doses of cortisone which will produce maximal desired effects rapidly are not necessary and are usually not desirable. It is distressing to hear of patients who after the first day or two of treatment with cortisone or ACTH become euphoric and have so much relief of symptoms that they jump out of bed and jump around the room; we know this euphoric state cannot be maintained for long without development of hypercortisonism, and the patients resent the loss of this exhilaration produced by reductions in dosage. Patients with marked osteoporosis run the risk of fractures during such stimulation.
Cortisone and ACTH cannot be expected to repair damage already done to affected joints, nor can they be expected to control symptoms from over-use of the damaged joints. When significant damage to joints is present, it is best to determine carefully how much of the disability is due to active rheumatoid arthritis and how much to mechanical injury. It is best to place the patient at rest in bed for 1 to 3 days to prevent the over-use of affected joints. Those that remain inflamed and are least affected by the period of rest should be watched carefully in determining the dosage of cortisone or ACTH.
There were several questions regarding libido during administration of cortisone. In our experience there were no instances of decreased libido with small suppressive doses of cortisone.
When small suppressive doses of cortisone were used, supplemental use of potassium salts was not necessary and seldom was it necessary to restrict the intake of sodium chloride.
DR. HENCH: This has been an interesting and instructive aftemoon, providing what one might call a " shakedown " session. It is exactly what we must have and will continue to have for many years to come. I hope no one will take offence at something I should like to say. Some who are now trying to use cortisone or ACTH as therapeutic agents, especially for chronic diseases such as rheumatoid arthritis, are, it seems to me, unduly disturbed by the difficulties of the moment. When the clinical result is excellent and no undesirable effects occur, the physician's spirit rises: "These hormones are wonder drugs ", he says; but in the face of difficulties (when it is not yet possible by present methods of administration to find an adequate dose free of side-effects, or when relapses occur) he be&omes prematurely discouraged. 0 We must not be over eager and impatient in this matter of developing a better, and perhaps a complete, understanding of the physiologic use of cortisone and ACTH, especially in chronic diseases. We lack the basic information to establish a truly physiologic method of administration.
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Those who are trying to develop, by trial and error and with concern for calculated risks, a reasonably safe and effective method of administration are to be encouraged. Their labours are so necessary, and have already been surprisingly fruitful.
But in contrast to the harassed " therapists " (whose responsibilities and feelings I share) are those whose objective is not so much a dosage-scheme for to-day, but a basic knowledge of the role of these and related hormones in the pathogenesis of rheumatic diseases. Such investigators, despite the practical pressures of the moment, must collect for us the vital information we now lack: How much endogenous cortisone and ACTH do normal persons develop in health and under stress ? how do the peripheral tissues of normal persons or rheumatic patients metabolize endogenous or exogenous cortisone or ACTH ?
It has taken many years to reach what might be called " first base ", to be able to demonstrate at will the potential reversibility or " suppressibility " of some of these diseased states and to discover agents for the study of this phenomenon. One must not be discouraged if " home plate"
has not yet been reached, for I am confident that it will be reached in time.
Degeperative Joint Disease of the Hip (Malum Coxae Senile, Osteo-arthritis of the Hip):
Relief In six of our eight cases, we obtained insufficient relief of pain after two weeks' intensive therapy to justify continuing the drug. The two patients who did derive significant relief have not been followed long enough to determine what the long-range effect will be.
We feel, therefore, that while cortisone is worth a trial in malum coxae, it is not the treatment of choice, but rather something to use in severe cases demanding desperate remedies.
DR. SOLOMON P. CARP (New York): Our findings in a similar study are in accord with those of Dr. Boots. We observed thirteen cases of advanced osteo-arthritis of the hip, the majority with bilateral involvement. Each had been studied by the orthopaedists and referred to us as serious and difficult problems. The complaints in all cases were severe pain, stiffness, and impairment of motion of the involved joints; x-ray films showed advanced degenerative changes and almost total loss of joint space.
With ACTH and cortisone treatment, ten of the thirteen showed considerable improvement, relief of pain, diminution of stiffness, and improved co-ordination of motion. All ten were able to move with greater facility and to perform such simple motions as walking up stairs and arising from a sitting position, but only two showed any significant change in the range of motion of the involved joints. ACTH and cortisone were employed in the treatment of twelve patients of whom six manifested the complete shoulder-hand syndrome and six were classified as acute or chronic incomplete shoulder-hand syndrome. In most instances small doses (40-60 mg. ACTH or 50-100 mg. cortisone daily for a period of 10 days to 2 weeks) led to good therapeutic results. In some cases pain and swelling were alleviated and normal motion of the extremity established within a few hours. Shoulder-hand syndromes following post-infarction states responded favourably. Once pain had subsided and increased motion had been established, physiotherapy was found useful.
Excellent results were observed in ten of the twelve patients, two experienced relief from pain but did not regain the full range of motion.
Discussion.-DR. SIDNEY S. BERKOWITZ (New York): Our findings have been similar to Dr. Sigler's. In eleven cases of reflex dystrophy of the upper extremity treated with cortisone and ACTH, the results compare favourably with those in patients treated with sympathetic nerve blocks. In fact, we observed good results with the use of the hormones in several cases who failed to respond to stellate ganglion blocks. In our small series, somewhat larger initial doses were required for the first 5 to 10 days than those commonly needed in rheumatoid arthritis. So far our results have been impressive, and certainly warrant further study. (1) Eleven treated with these compounds without manipulation; effective treatment in six.
(2) Three of five cases in Group 1 who were unresponsive to the steroids, were subjected to manipulation and the administration of ACTH or cortisone was continued; treatment completely effective in one.
(3) Three received the steroid for the first time after manipulation had been carried out; great improvement and recovery in two.
Nine of the fourteen patients were greatly improved or recovered completely. Maintenance doses were required for a limited time to overcome recurrence of symptoms during attempted rest periods. The trend of responsiveness of periarthritis of the shoulder to. ACTH I have had the opportunity of following many of the patients included in the series just reported by Dr. Ehrlich, and should like to sketch one of these briefly:
This patient is a woman who began to develop pain and disability in the left shoulder late in 1948. Within a few weeks her pain was almost constant and the range of motion was limited to 10 or 15 per cent. of normal. During the next year she was seen by at least six physicians of various specialties. Treatment included physical medicine, x-ray therapy, local injections at trigger points with alcohol and iodine, other injections at trigger points with procaine hydrochloride, brachial plexus blocks, and several manipulations of the shoulder joint under anaesthesia.
After admission to hospital the patient's condition deteriorated, until she was taking five to six doses of demerol each day. Within 2 to 3 hours of the change from placebos to cortisone, which was carried out successfully without her knowledge, the use of demerol was cut in half. Within a week from starting the cortisone, the demerol had been voluntarily discontinued and function at the left shoulder was rapidly returning toward normal. Within three to four weeks function was almost complete and the patient was pain-free. Cortisone was discontinued shortly thereafter, and the patient has remained well since then. That was almost a year ago.
There were other cases of this general nature in the series just described, and I believe this is what Dr. Ehrlich referred to when he talked about advanced and serious problems.
It would seem that further observations on the effects of cortisone are well warranted in these non-rheumatoid states.
DR. HENRY H. JORDAN (New York): The result of manipulation under general anaesthesia for periarthritis or adhesive capsulitis of the shoulder depends to a great extent on the surgeon's 485 group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from ANNALS OF THE RHEUMATIC DISEASES technique. Few, if any, recurrences of adhesions will be found after atraumatic manipulation, but adhesions are much more common when the emphasis is on force rather than on time. The use of cortisone to prevent the formation of adhesions after manipulation seems logical and should be tried whenever possible.
DR. NATHAN R. ABRAMS (Cincinnati, Ohio): My series is not large, but my five cases were considerably shorter in duration. All were treated within the first month of their illness with cortisone on an ambulatory basis. Of the five, one showed no improvement at any time; of the other four, one experienced great improvement and maintained it after the cessation of two weeks' therapy, but the other three promptly relapsed and later responded well to other methods, such as x-ray therapy and physical therapy. This seems to show that methods other than cortisone should be used in the early stages.
DR. STEINBROCKER: I should like to add that the proportion of early cases in Dr. Sigler's group was higher than in ours, so there will be some difference in our results. Neverthe less, our results coincided very much with his, the difference arising from the fact that all our cases but one were chronic, longstanding examples of the shoulder-hand syndrome.
DR Lymphadenopathy is frequently encountered in patients with rheumatoid arthritis. Lymphatic system involvement is an integral part of the pathology of Still's disease and may be found in Felty's syndrome. Lymph-node biopsies in a series of patients with rheumatoid arthritis revealed pathological evidence of giant follicular hyperplasia; in some instances this was accompanied by fusion of lymph follicles, a criterion considered to be one of the characteristics of malignancy. Other patients showed follicular hyperplasia not of the giant variety. Serial lymph-node sections in instances of non-specific follicular hyperplasia and true giant follicular lymphoblastoma were compared with similar material from our series of patients with rheumatoid arthritis. While the period of clinical observation of these patients is too short to permit a definitive statement as to the true nature of the lymph-node lesions observed, it is our tentative conclusion that the histologic picture of giant follicular lymnphoma (Brill-Symmers disease) may be simulated by the lymph-node lesions found in some cases of rheumatoid arthritis.
Discussion.-DR. WALLACE GRAHAM (Toronto, Canada): In 1948,. two of our patients with severe rheumatoid arthritis were found to have unusual enlargement of lymphatic glands:
(1) In a male aged 42, some were the size of a small walnut. The biopsy was reported as typical of giant follicular lymphoblastoma.
The differentiation between cortex and medulla no longer exists and a good proportion of the glandular tissue is composed of huge hyperplastic lymphoid follicles with greatly expanded germinal centres with a thin compressed rim of lymphocytes surrounding them. Within the germinal centres mitotic figures are fairly numerous, etc.
A synovial biopsy from the knee revealed the usual picture of rheumatoid arthritis. After deep x-ray therapy the glands temporarily diminished in size.
In 1950, biopsy of the glands was again carried out before and after the administration of cortisone. After 3 gm. cortone over 20 days the glands had almost completely disappeared. After cortisone, a large portion of the medulla was found to be replaced by fat. Germinal centres were numerous but small. The biopsy was reported as chronic lymphadenitis.
(2) A male, aged 38, presented a similar picture; the first biopsy was reported as giant follicular iymphoblastoma, and a synovial biopsy from the knee showed no significant lesion. This patient developed a tumour in association with a peroneal tendon. This also was non-malignant. A second biopsy of a gland in September, 1950, was reported as hyperplasia of a lymph node.
Both patients have now been under observation for three years and have shown no sign of malignancy. We feel that these glands represent an unusual hyperplasia in rheumatoid arthritis, but should agree with Dr. Motulsky that the histologic picture of giant follicular lymphoma may be simulated by the lymph-node lesions found in some cases of rheumatoid arthritis.
Gross Osteopathology of the Arthritides. By WILLIAM J. TOBIN, and T. D. STEWART, Washington, D.C. Gross pathological changes were observed in the arthritides; the material came from the collection of skeletal remains in the Department of Anthropology of the Smithsonian Institution, Washington, D.C. The specimens selected were carefully studied, photographed, and x-rayed. Various stages in the calcification of the ligaments of the spine were presented, with examples of complete fusion of the spine, considered to be the end result of an ankylosing type of arthritis of the spine. Degenerative changes with hypertrophic spur formation of the various joints were illustrated. The antiquity of the various types of arthritis was shown in a fused cervical spine from the 12th Egyptian Dynasty (about 2000 B.C.) interpreted as a Marie-Strumpell arthritis. Specimens showed arthritic changes secondary to trauma, postural habits, developmental conditions such as coxa vara, and slipped femoral epiphyses.
Discussion.-DR. DARRELL C. CRAIN, JR. (Washington, D.C.): This work deserves commendation from the purely physical aspect. The various museums in Washington contain more dried bones than ever Ezekiel saw in his famous vision. Dr. Tobin is the first who has tried to sort them and to bring some order out of chaos. It has been a tremendous physical task and he deserves the highest praise for the amount of time he has spent on this work.
Little of the material available in the various medical museums is properly catalogued, and little work has been done on the subject in recent years, Dr. Douglas Collins's book being about the only up-to-date study, but work of this sort is essential for a clear understanding of the basic mechanism in the arthritides, and Dr. Tobin and Dr. Stewart have made a valuable contribution.
DR. EDWARD F. ROSENBERG (Chicago, Ill.): There is much to be learned from the study of bone specimens, and I hope this work will continue. I should like to call attention to a particular field of study in relation to the pathology of rheumatic diseases, the problem of rheumatoid sacro-ileitis. Clinicians daily observe progressive destructive changes in roentgenograms from patients with rheumatoid spondylitis, but the literature contains no information on the histological nature of these lesions. I hope that the studies described to-day will, as they are continued, throw some light on this subject. DR. TOBIN: These specimens are quite old and are usually devoid of any soft tissue. Only the mummy specimens show any soft tissue, and even in these it is very difficult to make any study of the changes in the soft tissues.
I regret that time does not permit me to show additional specimens illustrating arthritic changes in the sacro-iliac joint, hip, and knees. Our paper is merely an introduction to this interesting subject. We have at the Smithsonian Institution approximately 20,000 skeletons from various geological and anthropological periods up to the present day, and so far, we have dusted off, so to speak, only the first row in the first room.
Effects of Some 11-Desoxysteroids in Rheumatoid Arthritis. By WILLIAM S. CLARK, HENRIK 0. TONNING, JOSEPH A. BLAIS, and WALTER BAUER, Boston, Mass.
Forty-five patients received the following 1 l-desoxysteroids: desoxycorticosterone, 21 -propionate, " saturated " desoxycorticosterone, testosterone, pregnenolone, dehydroisoandrosterone, 1 6-dehydropregnenolone, progesterone, A5-pregnene 3-(b), premarin, 21-diol-20-one, estradiol benzoate. In one patient, mineral and nitrogen balances were determined during the administration of testosterone, desoxycorticosterone, and cortisone-singly, together, and in binary combinations.
None of the steroids exhibited a significant antirheumatic effect in the dosages used. The mild subjective and objective improvement observed in some patients was no greater 487 group.bmj.com on October 14, 2017 -Published by http://ard.bmj.com/ Downloaded from ANNALS OF THE RHEUMATIC DISEASES than that noted during the administration of placebos. In. all cases the therapeutic results were classified as Grade IV (Steinbrocker) .
Desoxycorticosterone and testosterone did not quantitatively or qualitatively alter the antirheumatic effects of cortisone, although testosterone counteracted its effect on protein metabolism. Desoxycorticosterone had no adverse effect on the arthritis even in the presence of considerable salt retention.
These observations further suggest that only carbohydrate active corticosteroids are capable of suppressing rheumatoid arthritis, and they indicate that the antirheumatic effect of cortisone cannot be altered by desoxycorticosterone and/or testosterone.
Discussion.-DR. HOWARD F. POLLEY (Rochester, Minn.): Among the group of steroid substances chemically related to cortisone which we have tested at the clinic were six 1 1-desoxysteroid preparations.* Further data concerning three of these (desoxycorticosterone, A 5-pregnenolone, and 21-acetoxy-pregnenolone), are included in Dr. Clark's report. Our results were similar to those which he has reported.
The other 1 l-desoxysteroid preparations which we tried were 1 1-desoxycortisone (also known as substance S of Reichstein), 17-hydroxyprogesterone, and pregnenetriolone acetate. None of these preparations revealed any antirheumatic activity.
I concur with Dr. Clark's conclusions, that the 11-desoxysteroids are without antirheumatic activity in so far as we know how to use them at the present time.
DR. WILLIAM K. ISHMAEL (Oklahoma City, Okla.): Our preliminary report on the use of testosterone in rheumatoid arthritis was published in September, 1949; follow-up We have found it difficult, through lack of co-operation on the part of the obstetricians and lack of interest on the part of postpartum women. To get anything at all, we had to supply twice as much blood as we took away, and then the mother was frequently alarmed to find a transfusion being given; we found more of them were interested in a fancy fee than in transfusion. Unless there is more proof than we now have of some degree of permanent relief, it seems to me too difficult a problem in most communities to obtain sufficient quantities of postpartum plasma. DR. GRANIRER: We feel the same as Dr. Holbrook; that at present this is a somewhat difficult form of therapy, but no more than insulin in the early days. Whether pregnancy has more or less of the active substance cannot be determined at present. The premise was that during and after delivery there was a sharp increase in hormones which pregnancy might not always possess.
We expect 20 per cent. failures. How long will a patient stay in remission after treatment ?
Remissions varied from 3 weeks to 2 years. A patient in remission may require treatment every tissue calcification may occur in other areas. Specific therapy for this syndrome is so dramatic that an accurate early diagnosis is of utmost 'importance.
Acute calcifications may also occur at the elbow, wrist, interphalangeal joints of the hand and foot, hip joint, knee, and ankle. We are reporting a series of 31 cases encountered between 1943 and 1950, which have been adequately followed up; in the majority the region of the elbow, wrist, and hip was affected, in the order mentioned. During this same period, 389 cases of " subdeltoid bursitis " of the shoulder were treated; these were mostly acute with demonstrable calcification.
The pathology, symptoms and signs, and treatment of these lesions was discussed. Judicious x-ray therapy was considered the best method of management.
Discussion.-DR. GEORGE G. HAYDU (New York): Our experience is very much like that just reported. I should like to call attention to the period that precedes tissue calcification; you often find a period of mild complaint and undue stress in the areas of the tendons; inflammation often occurs before calcification, and also, at times, long after x-ray therapy. It is well to treat the underlying process in order to prevent any further recurrence.
DR. RUSSELL L. CECIL (New York): I had a friendly argument the other day with an orthopaedic colleague, who insisted that they had decided, after years of observation, that x-ray therapy had no value in the treatment of these self-limiting bursal conditions in the shoulder. I have always felt that x-ray therapy was valuable in acute bursitis of the shoulder and other -joints, but the orthopaedist insisted that the radiologists in his hospital were equally convinced that we were deceiving ourselves in using x-ray therapy on the shoulder; he thought that the shoulder would get well in a few days anyway, and that we were only wasting our time.
DR. Orro STEINBROCKER (New York): I am inclined to agree with Dr. Miller. I think, however, that the great value of local infiltration of procaine or a related substance, or the two-needle irrigation of the acute calcification, is a valuable procedure that should not be dismissed too lightly. Under ordinary circumstances the most practical procedure, according to our experience in these conditions, is radiation therapy, but when x-ray treatment is not available the infiltration of procaine or two-needle irrigation is a valuable technique to dispose of the symptoms and the calcium. They have given us at least as high a proportion of good results as radiation therapy, and have succeeded in some instances when radiation failed.
It is important to appreciate that in what we classify separately as hyperacute, acute, and chronic conditions, the indications are somewhat different. The patient with a hyperacute calcific tendinitis cannot tolerate irrigation or needling.while conscious. Such a patient is in too great pain and the local signs are too sensitive and extensive for such a procedure without a simple general anaesthetic, such as a barbiturate intravenously. Usually an injection of morphine or demerol will be satisfactory for needling a merely acute disorder in an ambulatory patient. A chronic condition is not quite as effectively treated, because the chronic symptoms represent a more complex problem, and a calcific deposit in the chronic involvement is merely a roentgenologic sign which may divert us from the true source of the symptoms.
DR. DARRELL C. CRAIN, JR. (Washington, D.C.): Those of you who have read the Rheumatism Reviews will recall that the last Review mentioned that more confusion surrounds the painful shoulder than any other subject, but I think we are'beginning to sort out that confusion. The condition discussed by Dr. Miller is certainly analogou$ to the condition of calcific deposits in the tendons of the shoulder. I should like to suggest that the term " calcareous tendinitis " or " calcific tendinitis " be used; it is a simple descriptive term, and one which could be readily adopted for the condition in or around any joint.
As regards treatment, I agree with Dr. Miller and should like to stress the importance of early x-ray therapy. In contrast to Dr. Steinbrocker's experience, my experience with needling has been somewhat disappointing. In the early cases, when needling may be successful, it is often too painful to be tolerated, and x-ray therapy is practically always successful; later, when the deposit is harder, needling may be of very little benefit and may serve to irritate the condition.
DR. HOWARD F. POLLEY (Rochester, Minn.): I should like to ask Dr. Miller whether he thinks the large calcium formations accumulate within the brief period that the symptoms come on. DR. MILLER: I am an orthopaedic surgeon myself, and when I develop an acute calcification associated with a joint, I shall choose to have x-ray therapy. I have confined my remarks this morning to acute calcifications associated with joints other than the shoulder. I did that because this disease is self-limiting, while in the similar shoulder lesions, where I am sure the pathology The Air Force is greatly concerned about this problem, and I think that Dr. Engleman's observations will enable us to measure what might be accomplished in treating this first or monophasic attack of rheumatic fever in these young adults without the use of hormones.
DR. HowARD C. COGGESHALL (Dallas, Texas): I have had occasion to follow some of these patients through-the Veterans' Administration, and I should like to raise one point. The adults with what was apparently rheumatic fever frequently have many muscular symptoms. Whether this is a variation common to adults, or whether it is a characteristic of veterans, I am not sure, but there is a great correlation between compensation and continued symptoms. Even though you find no evidence of heart disease, many of them will still not admit to being completely symptomfree. I think the problem of compensation always makes it difficult to evaluate veterans unless you have objective evidence of definite disease.
DR. ENGLEMAN: Dr. Brown asked about the incidence of streptococcal infection in adults. I must emphasize that this is a follow-up study and that we have no data concerning streptococcal infection before the onset of rheumatic disease. I think, in general, that there was a fairly good relationship between streptococcal infection and the onset of the initial attack.
As far as the dyspnoea was concerned, we felt this was a manifestation of cardiac neurosis. Dr. Coggeshall's point concerning the difficulty of the evaluation of the veteran who is receiving compensation is an excellent one. However, as far as arthralgia is concerned, we were impressed by the organic pattern. These patients were worse in the morning upon arising and were helped subjectively by aspirin, local heat, and by physical activity. We felt that most of these patients had genuine joint symptoms which were not satisfactorily explained. Benemid was administered orally on several different dose schedules to a group of more than 25 patients. Medication was continued over a period of several months. The effects of Benemid upon carefully controlled blood urate observations, upon the frequency and severity of gouty attacks, and upon urate excretion, and its low toxicity was discussed.
In some patients, Benemid was used in conjunction with colchicine and salicylates, while in other gouty patients, it was the sole medicament employed. The effect of Benemid on uric acid metabolism in normal subjects was also mentioned.
It is our belief that Benemid is of value in the long-term control of the disturbed gouty metabolism, and may prevent or minimize the frequency and/or severity of attacks, as well as the complications of this disease.
Discussion.-DR. RICHARD T. SMrrH (Philadelphia, Pa): We have had experience in fifteen patients with gouty arthritis, having treated them for a period of several months or more. When we first attempted to use Benemid, we used doses of two g. or more a day, and found some patients did not tolerate those doses so well. From experiences in using Benemid with penicillin, it was found that lower doses were successful when there was some renal impairment. Therefore, in gouty arthritis, we tried smaller doses, 0 5 g. daily for a week (one tablet), then increasing the dosage to 1 gr. (two tablets) in divided doses thereafter. Of the fifteen patients, three had chronic gouty arthritis and six were having increasingly frequent attacks. Nine of these patients had not been adequately controlled with acetylsalicylic acid and sodium bicarbonate, as evidenced by frequent attacks.
In eight of the fifteen patients attacks were precipitated by the therapy; none of these occurred during the first week, when they were receiving only 0 5 g. Benemid daily. The longest period of repeated attacks during the early stages of the Benemid therapy was 10 days. In only one of these patients was it very severe. The shortest period of increased joint difficulty was 3 days, and the average about 6 days.
Maintenance doses of colchicine were continued in four patients; in one of these no increased attacks occurred during the early Benemid therapy; in three there were some mild attacks with the maintenance dose.
Our patients have been warned in advance that they might anticipate some increased joint difficulty during the first few weeks of Benemid therapy. Expecting this, and having been instructed to take their colchicine, as they would for acute attacks in the past, they were well prepared in most instances for relief of their discomfort. 
We have also given sufficient sodium bicarbonate to produce alkalinization of the urine, particularly to prevent the possibility of precipitation of urate crystals in the kidney.
We have permitted a liberal diet to the patients throughout treatment, particularly after the first 2 or 3 weeks for those having the greatest amount of difficulty. We had no means of predicting which patients would suffer attacks during the early stages of Benemid therapy, but there is a suggestion that we might expect increased attacks in those whose gouty arthritis had been more severe just before treatment was started.
It may be possible to prevent these increased attacks with the Benemid therapy by giving smaller doses for a longer period. This study we have not yet completed.
One fact is outstanding, that we have a substance apparently superior to anything we have used before as a uricosuric agent, and that with just one to four Benemid tablets a day, many gouty patients are permitted to live an almost normal life with little or no recurrent disability.
DR. LocKiu: It should be emphasized that we are continually looking for something that will lower the blood uric acid or prevent attacks of gouty arthritis. Here is a substance which.has been found to be useful, and relatively non-toxic, and, in Buffalo, it has not precipitated acute attacks of gouty arthritis. I am surprised that Dr. Richard Smith has had so many in his series in Philadelphia.
However, itmust be remembered that we are using 0 5 to 10 g. twice a day, in conjunction with other means of treatment, except that the weekly administration of salicylates or cinchophen is omitted. It does not prevent the occurrence of acute attacks, nor does it replace colchicine. In the group we have studied, many patients have been followed for years, so that the pattern of attacks is well known, and it is felt fewer attacks of gouty arthritis have occurred.
DR. WILLIAM H. GOODSON (Kansas City, Mo): What is the effect of Benemid on acute gout and are there any complications ?
DR. EPHRAIM P. ENGLEMAN (San Francisco, Calif.): What is its advantage over aspirin? DR. NoRcRoss: In our experience, 1 g. Benemid daily was not as effective as reported by Dr. Smith. We were not able to maintain the maximal reduction of serum urate with this dose unless considerable renal impairment was present. Because of the absence of toxicity, we have continued to use 2 g. daily in the majority of our patients.
Dr. Lockie answered the question about provocation of acute gouty arthritis by Benemid. We have not observed any significant incidence of acute attacks precipitated by Benemid therapy.
We believe that there has been a reduction in the number of attacks of gouty arthritis in this group, although some have had acute attacks after a year of Benemid administration. I think that much more time must elapse before we can make a definite evaluation.
Two patients who developed acute gouty arthritis during Benemid administration were not relieved by larger doses; we employed therapeutic courses of colchicine, and ACTH was used successfully in one patient.
The dosage of salicylates necessary to produce the same continued increase of urate excretion as that observed with Benemid has not been tolerated by many patients. Because there is also a rapid decrease in the salicylate effect on urate excretion with prolonged administration, we have used salicylates in the past on an intermittent, rather than on a continuous, schedule. We believe that Benemid is a better drug than the salicylates because it is not toxic and its effect on urate metabolism is prolonged indefinitely. CHAIRMAN HENCH: Just a word before we start this panel discussion. The, papers and discussions of yesterday show that the unjustified hopes and the unjustified fears concerning cortisone and ACTH are rapidly disappearing. The present status of cortisone and ACTH and their application to rheumatic and other diseases is somewhat analogous to the situation which would have occurred had insulin been discovered before we discovered methods for determining the sugar in blood or urine or knew anything about the metabolism of carbohydrates in the. normal or the diabetic. Until methods have been developed whereby one can estimate the quantities of cortisone and ACTH present in blood or bodily tissues of normal and diseased persons, and until we have learned much more than we know now about the metabolism of these hotmones, we can only use them therapeutically by a process of intelligent trial and error, by making mistakes and learning from them.
We will discuss first a few questions on rheumatic fever, and on gout, and then proceed to rheumatoid arthritis. The first question is this: How long must cortisone and ACTH be kept up in acute rheumatic fever ? DR. HOLBROOK: Many patients with acute rheumatic fever show complete subsidence of symptoms after receiving cortisone or ACTH for only a week or 10 days, but others do not. Therefore, in order to provide the maximum chance of preventing cardiac damage, we consistently give the hormones for 4 weeks. CHAIRMAN: We will now turn to gout. Are cortisone and ACTH any better than colchicine ? If so, which is the better, cortisone or ACTH ? DR. ROBINSON: I believe that colchicine, as it is customarily used, will take care of perhaps 90 per cent. of acute gouty attacks. For those patients who do not respond to colchicine, ACTH offers an excellent treatment. We believe that the dose of ACTH must be large, 100 mg. a day of a long-acting, or up to 200 mg. per day of short-acting, preparation. It must be combined with colchicine, and colchicine in maintenance doses (two to three tablets a day) should be continued for a while to prevent the occurrence of a " withdrawal attack ". In our experience, cortisone has not been as satisfactory as ACTH in the treatment of acute gouty arthritis.
CHAIRMAN: Are cortisone and ACTH useful in chronic gouty arthritis ? DR. ROBINSON: I don't believe anyone has had enough experience to justify any statement. DR. BOLAND: Our experience with cortisone and ACTH in the treatment of chronic gouty arthritis has been limited to a few cases. In general we are not convinced that these substances will produce persistent relief of chronic articular disability over long periods, and we are not sure that their uninterrupted use actually lessens the number of acute recurrent attacks. I DR. RAGAN: It will be difficult to synthesize an ACTH peptide. These peptides have been found to be of rather high molecular weight, and in our experience so far, there has not been much difference between the peptides and whole ACTH.
CHAIRMAN: Should the use of cortisone and ACTH still be considered more or less experimental ? developed spontaneous fractures during cortisone therapy; two of these were compression fractures of the lower dorsal spine and the other a fracture of a femoral neck. In view of the fact that spontaneous fractures are not uncommon in patients with Cushing's disease, we believe that this complication may be related to cortisone therapy-to us it appears likely that osseus demineralization may have been accelerated by the induced state of hypercortisonism. The possibility of this complication must be kept in mind in considering cortisone or ACTH therapy in older patients with evidences of skeletal osteoporosis from senility and from rheumatoid arthritis.
CHAInMAN: Is thrombophlebitis ever a definite side-effect from cortisone or ACTH ? DR. ROBINSON: The occasional development of thrombophiebitis during or ofter the use of these hormones raises the question whether it is related to the treatment oris co-incidental. We have been somewhat concerned about this, because we had four cases of thrombophlebitis among our first thirty patients. In each instance, the thrombophlebitis developed when the dosage was being decreased or had just been discontinued. Two instances were in patients in whom thrombophlebitis might be expected, one being a recurrence at the site of a previous attack 2 years before. The other two instances were in young people and the circumstances were rather unusual.
We have heard some statistics at this meeting which place the incidence of thrombotic occurrences during hormonal therapy between 1*7 and 2-1 per cent. Has anyone any figures of the incidence of thrombophlebitis in rheumatoids who have not received cortisone or ACTH ?
CHAIRMAN: When the members of the panel were talking about this last night, none had any statistics on the " natural occurrence " of thrombophlebitis among rheumatoid patients.
Among our early patients who received cortisone or ACTH, two developed thrombophlebitis when we were withdrawing or had just withdrawn cortisone, and we became somewhat concerned. Then we were about to begin giving cortisone to another patient on a Monday, but that particular patient developed thrombophlebitis on the Saturday before. So we do not know the final answer.
Next question: How often do cortisone and ACTH produce significant hypothyroidism? DR. ROBINSON: That depends on how you define the term " significant ". In our experience, some 85 per cent. of patients with rheumatoid arthritis on cortisone or ACTH have shown laboratory evidence of decreased thyroid function, as indicated by determinations of protein-bound iodine and the radio-active iodine uptake. Under ACTH and cortisone treatment, the basal metabolic rate is not reliable as an index of thyroid hypofunction.
In our experience, all the cases of elevation of blood cholesterol reported as a complication of prolonged treatment have been associated with evidences of hypothyroidism; the hypercholesterolaemia is corrected ty the addition of dessicated thyroid. If it is asked from the practical viewpoint, how often is it necessary to add thyroid to maintain the clinical effectiveness of these hormones, I must reply that to date, we have seen no patient who required added thyroid to maintain the therapeutic effectiveness of cortisone. Others, however, have reported seeing such patients. We have observed four out of nineteen patients in whom thyroid supplementation was clearly necessary in order to maintain the therapeutic effect of ACTH, and in other patients, on either hormone, we 
